BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19542455)

  • 1. The transmembrane E3 ligase GRAIL ubiquitinates and degrades CD83 on CD4 T cells.
    Su LL; Iwai H; Lin JT; Fathman CG
    J Immunol; 2009 Jul; 183(1):438-44. PubMed ID: 19542455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus type 1 ICP0 induces CD83 degradation in mature dendritic cells independent of its E3 ubiquitin ligase function.
    Heilingloh CS; Mühl-Zürbes P; Steinkasserer A; Kummer M
    J Gen Virol; 2014 Jun; 95(Pt 6):1366-1375. PubMed ID: 24643878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The single subunit transmembrane E3 ligase gene related to anergy in lymphocytes (GRAIL) captures and then ubiquitinates transmembrane proteins across the cell membrane.
    Lineberry N; Su L; Soares L; Fathman CG
    J Biol Chem; 2008 Oct; 283(42):28497-505. PubMed ID: 18713730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD83 expression is a sensitive marker of activation required for B cell and CD4+ T cell longevity in vivo.
    Prazma CM; Yazawa N; Fujimoto Y; Fujimoto M; Tedder TF
    J Immunol; 2007 Oct; 179(7):4550-62. PubMed ID: 17878352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus type 1 induces CD83 degradation in mature dendritic cells with immediate-early kinetics via the cellular proteasome.
    Kummer M; Turza NM; Muhl-Zurbes P; Lechmann M; Boutell C; Coffin RS; Everett RD; Steinkasserer A; Prechtel AT
    J Virol; 2007 Jun; 81(12):6326-38. PubMed ID: 17428858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10/MARCH1-dependent mechanism.
    Chattopadhyay G; Shevach EM
    J Immunol; 2013 Dec; 191(12):5875-84. PubMed ID: 24218453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: The transmembrane E3 ligase GRAIL ubiquitinates the costimulatory molecule CD40 ligand during the induction of T cell anergy.
    Lineberry NB; Su LL; Lin JT; Coffey GP; Seroogy CM; Fathman CG
    J Immunol; 2008 Aug; 181(3):1622-6. PubMed ID: 18641297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells.
    Anandasabapathy N; Ford GS; Bloom D; Holness C; Paragas V; Seroogy C; Skrenta H; Hollenhorst M; Fathman CG; Soares L
    Immunity; 2003 Apr; 18(4):535-47. PubMed ID: 12705856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83.
    von Rohrscheidt J; Petrozziello E; Nedjic J; Federle C; Krzyzak L; Ploegh HL; Ishido S; Steinkasserer A; Klein L
    J Exp Med; 2016 Aug; 213(9):1685-94. PubMed ID: 27503071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells.
    Seroogy CM; Soares L; Ranheim EA; Su L; Holness C; Bloom D; Fathman CG
    J Immunol; 2004 Jul; 173(1):79-85. PubMed ID: 15210761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic expression of a CD83-immunoglobulin fusion protein impairs the development of immune-competent CD4-positive T cells.
    Lüthje K; Cramer SO; Ehrlich S; Veit A; Steeg C; Fleischer B; Bonin Av; Breloer M
    Eur J Immunol; 2006 Aug; 36(8):2035-45. PubMed ID: 16841299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin ligase MARCH 8 cooperates with CD83 to control surface MHC II expression in thymic epithelium and CD4 T cell selection.
    Liu H; Jain R; Guan J; Vuong V; Ishido S; La Gruta NL; Gray DH; Villadangos JA; Mintern JD
    J Exp Med; 2016 Aug; 213(9):1695-703. PubMed ID: 27503069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene related to anergy in lymphocytes (GRAIL) expression in CD4+ T cells impairs actin cytoskeletal organization during T cell/antigen-presenting cell interactions.
    Schartner JM; Simonson WT; Wernimont SA; Nettenstrom LM; Huttenlocher A; Seroogy CM
    J Biol Chem; 2009 Dec; 284(50):34674-81. PubMed ID: 19833735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD83 expression in CD4+ T cells modulates inflammation and autoimmunity.
    Reinwald S; Wiethe C; Westendorf AM; Breloer M; Probst-Kepper M; Fleischer B; Steinkasserer A; Buer J; Hansen W
    J Immunol; 2008 May; 180(9):5890-7. PubMed ID: 18424708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannose-Capped Lipoarabinomannan from Mycobacterium tuberculosis Induces CD4+ T Cell Anergy via GRAIL.
    Sande OJ; Karim AF; Li Q; Ding X; Harding CV; Rojas RE; Boom WH
    J Immunol; 2016 Jan; 196(2):691-702. PubMed ID: 26667170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel E3 ubiquitin ligase substrate screen identifies Rho guanine dissociation inhibitor as a substrate of gene related to anergy in lymphocytes.
    Su L; Lineberry N; Huh Y; Soares L; Fathman CG
    J Immunol; 2006 Dec; 177(11):7559-66. PubMed ID: 17114425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression.
    Lin JT; Lineberry NB; Kattah MG; Su LL; Utz PJ; Fathman CG; Wu L
    J Immunol; 2009 May; 182(10):5919-28. PubMed ID: 19414743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of gene related to anergy in lymphocytes is associated with Notch-mediated human T cell suppression.
    Kostianovsky AM; Maier LM; Baecher-Allan C; Anderson AC; Anderson DE
    J Immunol; 2007 May; 178(10):6158-63. PubMed ID: 17475842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E3 ubiquitin ligase GRAIL controls primary T cell activation and oral tolerance.
    Kriegel MA; Rathinam C; Flavell RA
    Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16770-5. PubMed ID: 19805371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD83 regulates splenic B cell maturation and peripheral B cell homeostasis.
    Lüthje K; Kretschmer B; Fleischer B; Breloer M
    Int Immunol; 2008 Aug; 20(8):949-60. PubMed ID: 18544574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.